Skip to content
  • Log in
CKAN
  • Datasets
  • Organizations
  • Groups
  • About
  1. Home
  2. Organizations
  3. test_moissonnage_selune
  4. Bortezomib combined with...

Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.

Followers
0

Organization

test_moissonnage_selune

test_moissonnage_selune

There is no description for this organization

Social

  • Twitter
  • Facebook

License

No License Provided

  • Dataset
  • Groups
  • Activity Stream

Activity Stream

  • About CKAN
  • CKAN API
  • CKAN Association
  • Open Data

Powered by CKAN